Vorträge auf der European Stroke Organisation Conference (ESO-WSO)

In den nächsten Tagen werden vom Institut für Klinische Epidemiologie und Biometrie mehrere Vorträge auf der European Stroke Organisation Conference (ESO-WSO) gehalten:

SAMSTAG, 07.11.2020
Felipe Montellano:  10:50-10:55 Uhr
N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE (NT-PROBNP) IMPROVES THE PREDICTIVE ACCURACY OF THE ACUTE STROKE REGISTRY AND ANALYSIS OF LAUSSANE (ASTRAL) SCORE. RESULTS OF THE SICFAIL STUDY
Session: Rapid Communications 04: Prognosis and Clinical Outcome (07.11.2020, 10:30-11:15 Uhr)

SONNTAG, 08.11.2020
Viktoria Rücker: 07:10-07:20 Uhr
EXPLAINING THE DECLINE IN STROKE MORTALITY DUE TO CHANGES IN TREATMENT AND RISK FACTORS IN GERMANY: THE GERMAN IMPACT STROKE MODEL
Session: Scientific Communications 15: Epidemiology of Stroke Including Long-term Outcomes (08.11.2020, 06:25-08:00 Uhr)

Felizitas Eichner:  07:20-07:30 Uhr
CROSS-SECTIONAL STUDY INVESTIGATING THE UNDERSTANDING OF THE INFORMED CONSENT PROCEDURE OF A SECONDARY PREVENTION TRIAL AMONG STROKE PATIENTS – THE INA STUDY
Session: Scientific Communications 20: Stroke in Women and the Young (08.11.2020, 06:25-08:00 Uhr)

Kathrin Ungethüm: 07:40-07:50 Uhr
CARDIAC DYSFUNCTION AND FUNCTIONAL OUTCOME IN ISCHEMIC STROKE PATIENTS WITH DIABETES: PRELIMINARY RESULTS FROM THE SICFAIL (STROKE-INDUCED CARDIAC FAILURE IN MICE AND MEN) COHORT STUDY
Session: Scientific Communications 5: Biomarkers of Stroke Risk and Prognosis (08.11.2020, 06:25-08:00 Uhr)

MONTAG, 09.11.2020
Kirsten Haas:  06:50-07:00 Uhr
BASELINE CLINICAL AND DEMOGRAPHIC DIFFERENCES OF AF-PATIENTS UNDER DIFFERENT ANTICOAGULATION SCHEMES PRESTROKE: FIRST RESULTS FROM THE REGISTRY OF ACUTE STROKE UNDER NOVEL ORAL ANTICOAGULANTS-PRIME (RASUNOA-PRIME)
Session: Scientific Communications 21: Heart and Brain (09.11.2020, 06:25-08:00 Uhr)